Otsuka Holdings
4578.T
#642
Rank
C$54.67 B
Marketcap
C$104.36
Share price
-1.79%
Change (1 day)
37.13%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: C$1.46 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are C$14.47 Billion. In 2023 the company made an earning of C$1.46 Billion a decrease over its 2022 earnings that were of C$1.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023C$1.46 B-20.93%
2022C$1.85 B-12.7%
2021C$2.12 B-19.92%
2020C$2.65 B13.9%
2019C$2.33 B52.07%
2018C$1.53 B11.22%
2017C$1.38 B-36.03%
2016C$2.15 B31.15%
2015C$1.64 B
2013C$3.41 B33.52%
2012C$2.55 B-4.65%
2011C$2.68 B45.53%
2010C$1.84 B